N-[2-({1-[1-(4-chlorophenyl)cyclobutyl]-1,2,3,4-tetrahydroisoquinolin-7-yl}oxy)ethyl]-6-methoxypyridine-3-sulfonamide hydrochloride | 1190642-74-0

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 四氢异喹啉
• 英文名称: N-[2-({1-[1-(4-chlorophenyl)cyclobutyl]-1,2,3,4-tetrahydroisoquinolin-7-yl}oxy)ethyl]-6-methoxypyridine-3-sulfonamide hydrochloride
• 英文别名: N-[2-[[1-[1-(4-chlorophenyl)cyclobutyl]-1,2,3,4-tetrahydroisoquinolin-7-yl]oxy]ethyl]-6-methoxypyridine-3-sulfonamide;hydrochloride
• CAS: 1190642-74-0
• 化学式: C₂₇H₃₀ClN₃O₄S*ClH
• 分子量: 564.533
• InChiKey: QDXKDUCHWCUFQX-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  4.83
• 重原子数：
  37
• 可旋转键数：
  9
• 环数：
  5.0
• sp3杂化的碳原子比例：
  0.37
• 拓扑面积：
  97.9
• 氢给体数：
  3
• 氢受体数：
  7

文献信息

• TETRAHYDROISOQUINOLINES, PHARMACEUTICAL COMPOSITIONS CONTAINING THEM, AND THEIR USE IN THERAPY
  申请人：Amberg Wilhelm

  公开号：US20110105502A1

  公开（公告）日：2011-05-05

  The present invention relates to tetrahydroisoquinoline of the formula (I) or a physiologically tolerated salt thereof. The invention relates to pharmaceutical compositions comprising such tetrahydroisoquinolines, and the use of such tetrahydroisoquinolines for therapeutic purposes. The tetrahydroisoquinolines are GlyT1 inhibitors.

  本发明涉及式(I)的四氢异喹啉或其生理上可耐受的盐。本发明涉及包含这种四氢异喹啉的药物组合物，以及使用这种四氢异喹啉进行治疗目的的用途。这些四氢异喹啉是GlyT1抑制剂。
• Tetrahydroisoquinolines, pharmaceutical compositions containing them, and their use in therapy
  申请人：Amberg Wilhelm

  公开号：US20130203749A1

  公开（公告）日：2013-08-08

  The present invention relates to tetrahydroisoquinoline of the formula (I) or a physiologically tolerated salt thereof. The invention relates to pharmaceutical compositions comprising such tetrahydroisoquinolines, and the use of such tetrahydroisoquinolines for therapeutic purposes. The tetrahydroisoquinolines are GlyT1 inhibitors.

  本发明涉及公式（I）的四氢异喹啉或其生理上可容忍的盐。本发明涉及包含此类四氢异喹啉的制药组合物，以及使用此类四氢异喹啉进行治疗的用途。这些四氢异喹啉是GlyT1抑制剂。
• US8653100B2
  申请人：——

  公开号：US8653100B2

  公开（公告）日：2014-02-18
• US8957089B2
  申请人：——

  公开号：US8957089B2

  公开（公告）日：2015-02-17
• [EN] TETRAHYDROISOQUINOLINES, PHARMACEUTICAL COMPOSITIONS CONTAINING THEM, AND THEIR USE IN THERAPY<br/>[FR] TÉTRAHYDROISOQUINOLÉINES, COMPOSITIONS PHARMACEUTIQUES LES CONTENANT ET LEUR UTILISATION EN THÉRAPIE
  申请人：ABBOTT GMBH & CO KG

  公开号：WO2009121872A2

  公开（公告）日：2009-10-08

  The present invention relates to tetrahydroisoquinoline of the formula (I) or a physiologically tolerated salt thereof. The invention relates to pharmaceutical compositions comprising such tetrahydroisoquinolines, and the use of such tetrahydroisoquinolines for therapeutic purposes. The tetrahydroisoquinolines are GIyT1 inhibitors.